Lakefront Biotherapeutics (GLPGF) Financials

GLPGF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 ? -3.7 billion
March 31, 2026 3.9 billion 137.0 million
Dec. 31, 2025 4.0 billion 200.3 million
Sept. 30, 2025 4.8 billion 1.5 billion

GLPGF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 ? ?
March 31, 2026 -90.6 million ?
Dec. 31, 2025 -51.6 million ?
Sept. 30, 2025 -76.8 million -14.9 million

GLPGF Net Income

No data available :(

GLPGF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 3.4 billion - -
March 31, 2026 3.4 billion - 7.4 million
Dec. 31, 2025 3.5 billion 6.1 million 8.1 million
Sept. 30, 2025 4.2 billion - 10.0 million

GLPGF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 79.9 million
March 31, 2026 79.1 million
Dec. 31, 2025 77.4 million
Sept. 30, 2025 77.3 million

GLPGF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 29.1 million 25.6 million 3.2 million
March 31, 2026 141487 35.6 million 40.8 million 3.2 million
Dec. 31, 2025 1.9 million 126.2 million 52.1 million -3.5 million
Sept. 30, 2025 3.3 million 86.7 million 40.5 million 3.3 million

GLPGF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 13.8 million 10.4 million
March 31, 2026 7.5 million 5.5 million
Dec. 31, 2025 1.1 billion 533952
Sept. 30, 2025 83.5 million 12.7 million

GLPGF

Price: $26.24

52 week price:
22.39
48.70

Earnings Per Share: 10.40 USD

P/E Ratio: 4.68

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 3.2 billion

Links: